MaryKMurrayMD
General Surgery • Akron, OHBreast
Assistant Professor, General Surgery, Northeastern Ohio Medical Univ
Dr. Murray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2603 W Market St
Ste 210
Akron, OH 44313Phone+1 330-873-9700Fax+1 330-873-9702
Education & Training
Akron General Medical Center/NEOMEDFellowship, Breast Surgical Oncology, 2005 - 2006- Cleveland Clinic Foundation/Akron GeneralResidency, Surgery, 2002 - 2005
- Cleveland Clinic Foundation/Akron GeneralResidency, Family Medicine, 2000 - 2001
- Akron General Medical Center/NEOMEDInternship, Transitional Year, 1998 - 1999
Wright State University Boonshoft School of MedicineClass of 1998
Certifications & Licensure
OH State Medical License 1989 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow The Society of Surgical Oncology
- CMS Meaningful Use Stage 1 Certification Horizon Ambulatory Care EHR, McKesson Corporation, 2014
- Fellow American College of Surgeons
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 1 citationsCombined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01 - 1 citationsOmission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care.Michelle J Hong, Sharon S Lum, Elisabeth Dupont, Marissa Howard-McNatt, Akiko Chiba
The Journal of Surgical Research. 2022-11-01 - 3 citationsGenomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky
JCO Precision Oncology. 2022-09-01
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
